How does R0L's PS Ratio compare to its peers?

R0L is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.6x).

How does R0L's PS Ratio compare vs other companies in the DE Healthcare Industry?

R0L is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Healthcare industry average (0.6x).

What is R0L's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate R0L's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of R0L when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate R0L's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

J FrontierLtd DB:R0L Stock Report

Last Price

€18.40

Market Cap

€45.4m

7D

0%

1Y

-36.6%

Updated

12 Oct, 2024

Data

Company Financials

J Frontier Co.,Ltd.

DB:R0L Stock Report

Market Cap: €45.4m

R0L Stock Overview

Engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. More details

R0L fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Revenue has declined by 0.8% over the past year

Does not have a meaningful market cap (€7B)

My Notes

Capture your thoughts, links and company narrative

J Frontier Co.,Ltd. Competitors

VITA 34

XTRA:V3V

€70.8m

SYNLAB

HMSE:SYAB

€2.5b

Maternus-Kliniken

XTRA:MAK

€29.4m

Gesundheitswelt Chiemgau

MUN:JTH

€23.8m

Price History & Performance

Summary of share price highs, lows and changes for J FrontierLtd
Historical stock prices
Current Share Price	JP¥18.40
52 Week High	JP¥30.70
52 Week Low	JP¥16.10
Beta	0.49
1 Month Change	0%
3 Month Change	0%
1 Year Change	-36.61%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-38.56%

Recent News & Updates

Recent updates

Shareholder Returns

	R0L	DE Healthcare	DE Market
7D	0%	1.8%	1.0%
1Y	-36.6%	30.4%	12.7%

Return vs Industry: R0L underperformed the German Healthcare industry which returned 22.6% over the past year.

Return vs Market: R0L underperformed the German Market which returned 14% over the past year.

Price Volatility

Is R0L's price volatile compared to industry and market?
R0L volatility
R0L Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.7%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.3%

Stable Share Price: R0L's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine R0L's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2008	255	Atsuhiro Nakamura	jfrontier.jp

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy.

J Frontier Co.,Ltd. Fundamentals Summary

How do J FrontierLtd's earnings and revenue compare to its market cap?
R0L fundamental statistics
Market cap	€45.41m
Earnings (TTM)	-€10.49m
Revenue (TTM)	€104.28m

0.4x

P/S Ratio

-4.3x

P/E Ratio

Is R0L overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
R0L income statement (TTM)
Revenue	JP¥17.01b
Cost of Revenue	JP¥9.08b
Gross Profit	JP¥7.93b
Other Expenses	JP¥9.64b
Earnings	-JP¥1.71b

Last Reported Earnings

Feb 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-346.37
Gross Margin	46.62%
Net Profit Margin	-10.05%
Debt/Equity Ratio	105.3%

How did R0L perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/12 10:51
End of Day Share Price	2024/07/15 00:00
Earnings	2024/02/29
Annual Earnings	2023/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

J Frontier Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Keita Fujino	The Stock Research Center